Psychemedics

Psychemedics CROIC

The Cash Return on Invested Capital (CROIC) of Psychemedics (PMDI) as of Nov 5, 2026 is 16.41 %. In the previous year, Cash Return on Invested Capital (CROIC) was -24.54 % — a change of -166.90% (higher).

CROIC

16.41 %

YoY

-166.90%

Last updated:

Cash Return on Invested Capital (CROIC) of Psychemedics is 2024 16.41 % . Cash Return on Invested Capital (CROIC) of Psychemedics was 2023 -24.54 % . It decreases by -166.90% higher compared to the previous year.

The Psychemedics CROIC history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

CROIC
Date
CROIC
Jan 1, 2017
36.14 USD
Jan 1, 2018
33.07 USD
Jan 1, 2019
13.52 USD
Jan 1, 2020
-31.80 USD
Jan 1, 2021
1.81 USD
Jan 1, 2022
42.46 USD
Jan 1, 2023
-24.54 USD
Jan 1, 2024
16.41 USD
The Psychemedics CROIC history
YEARCROICYoY
16.41 %-166.90%
-24.54 %-157.78%
42.46 %+2,250.37%
1.81 %-105.68%
-31.80 %-335.17%
13.52 %-59.11%
33.07 %-8.48%
36.14 %-5.48%
38.23 %+137.22%
16.12 %-199.24%
-16.24 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Psychemedics Stock analysis

What does Psychemedics do? Psychemedics Corp provides drug testing services analyzing hair samples for drug presence, offering historical usage patterns and approximate drug intake levels. The company charges customers a per-unit fee for each tested sample, including training for sample collection and storage of positive results. Their primary service targets clients needing drug testing solutions, particularly in sectors requiring regular monitoring of substance use. The firm's technology focuses on hair analysis to deliver detailed insights into drug consumption over time. Psychemedics Corp's revenue model is based on per-unit testing fees, with services including sample collection training and storage of positive samples. Customers pay for each sample tested, leveraging the company's hair analysis technology to monitor drug use patterns. The business operates within the drug testing services segment, serving clients who require reliable and historical data on substance abuse. The company's drug testing services are designed for customers seeking detailed historical data on drug use, with results indicating both the amount ingested and usage patterns over time. Psychemedics Corp generates income through fixed fees per sample tested, covering the full service including sample collection training and positive sample storage. Their focus remains on delivering accurate, long-term drug usage insights through hair analysis. Psychemedics is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Psychemedics stock

Cash Return on Invested Capital (CROIC) of Psychemedics is 16.41 % in 2024.

Cash Return on Invested Capital (CROIC) of Psychemedics changed from -24.54 % to 16.41 %, representing a -166.90% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Cash Return on Invested Capital (CROIC) Psychemedics since 2006 – with annual values, charts, and detailed analysis.

CROIC measures the cash return generated on invested capital. Unlike ROIC, it uses free cash flow instead of accounting earnings, providing a purer profitability measure.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Cash Return on Invested Capital (CROIC)'s Psychemedics with sector peers and the industry average to assess whether it is attractive.

To evaluate Cash Return on Invested Capital (CROIC)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Cash Return on Invested Capital (CROIC).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — Psychemedics

All Key Metrics — Psychemedics